Social Anxiety Disorder. Social phobias
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of Social Anxiety Disorder based on Structured Clinical Interview for DSM-5 (SCID-5) Age range 20 to 30 Years Level of education, minimum diploma Consent of the participants to attend the treatment sessions
Exclusion criteria
Exclusion criteria: Psychiatric disorders such as psychotic disorders and personality disorders and comorbid disorders such as other anxiety disorders, mood disorders, body dysmorphic disorder and substance use disorders Addictive behaviors such as Internet Addiction (measured in the context of the interview) Medical disorders (assessment by reviewing the file and medical history) Receiving simultaneous psychological interventions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fear of Positive Evaluation score on the Fear of Positive Evaluation Scale (FPES). Timepoint: The variable will be assessed one week before the start of treatment and at the baseline stage. It will then be assessed four times during treatment. At the end of treatment and then with a 3 months follow-up, the assessment will be repeated. Method of measurement: Fear of Positive Evaluation Scale (FPES).;Emotion regulation score in the Emotion Regulation Questionnaire (ERQ). Timepoint: The variable will be assessed one week before the start of treatment and at the baseline stage. It will then be assessed four times during treatment. At the end of treatment and then with a 3 months follow-up, the assessment will be repeated. Method of measurement: Emotion Regulation Questionnaire (ERQ).;Interpersonal Problems score in the Inventory of Interpersonal Problems (IIP-32). Timepoint: The variable will be assessed one week before the start of treatment and at the baseline stage. It will then be assessed four times during treatment. At the end of treatment and then with a 3 months follow-up, the assessment will be repeated. Method of measurement: Inventory of Interpersonal Problems (IIP-32).;Score of Painful Physical Symptoms in the Visual Analogue Scale (VAS). Timepoint: The variable will be assessed one week before the start of treatment and at the baseline stage. It will then be assessed four times during treatment. At the end of treatment and then with a 3 months follow-up, the assessment will be repeated. Method of measurement: Visual Analogue Scale (VAS).;Fear of Negative Evaluation score in the Brief Fear of Negative Evaluation-II (BFNE-II). Timepoint: The variable will be assessed one week before the start of treatment and at the baseline stage. It will then be assessed four times during treatment. At the end of treatment and then with a 3 months follow-up, the assessment will be repeated. Method of measurement: Brief Fear of Negative Evaluation-II (BFNE-II). | — |
Countries
Iran (Islamic Republic of)
Contacts
The Semnan University